Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning

Bogdana Suchorska, Ulrich Schüller, Annamaria Biczok, Markus Lenski, Nathalie L. Albert, Armin Giese, Friedrich-Wilhelm Kreth, Birgit Ertl‐Wagner, Jörg‐Christian Tonn, Michael Ingrisch

European Journal of Cancer · 2018 · 59 citations · 28 references

Concepts

References

28